Services

Global Mergers

One global firm: Seamless economic support

As merger control becomes increasingly global, businesses face the challenge of navigating diverse regulatory frameworks across multiple jurisdictions. With heightened scrutiny from competition authorities worldwide, cross-border mergers demand a strategic, coordinated approach to ensure consistency across jurisdictions and avoid unnecessary costs.

At CRA, we leverage a global network of competition and antitrust experts across 17 offices – from the United States to Europe to Asia – providing comprehensive, strategic and streamlined support for large, multi-jurisdictional mergers. CRA supports clients all over the world and in front of many antitrust enforcement agencies.

Our team is adept at navigating complex regulatory environments across multiple jurisdictions, providing consistent economic advocacy, a streamlined approach to fact gathering, simplified relationships with counsel and the business, reduced economic management costs, tailored economic analysis, and regulatory guidance.

CRA has been involved with some of the largest and most complex global deals, including recent work on Microsoft/Activision, Broadcom/VMware, and Cisco/Splunk and advised many more global companies and law firms on both sides of the Atlantic and across several more jurisdictions.

  • 85+
    Senior economists across 17 offices
  • 340+
    Competition consultants
  • 36+
    Global mergers
  • 41
    Who’s Who Legal recognized experts

Engagements

  • 01
    CRA advises Lesaffre on yeast extract acquisitions and global merger clearances
    CRA supported Lesaffre in its acquisitions of DSM-Firmenich’s yeast extract business and its joint venture with Zilor Group. Lesaffre acquired a 70% stake in...
    View engagement
  • 02
    CMA closes its merger inquiry into the Microsoft/OpenAI partnership
    The CMA investigated whether the terms of the partnership led to Microsoft exerting de facto control over OpenAI and whether the benefits brought by the...
    View engagement
  • 03
    EC unconditionally approves $16.5bn acquisition of Catalent by Novo Holdings
    By providing additional fill-finish capacity, the transaction would enable Novo Nordisk to reach more obesity and diabetes patients faster. The Commission...
    View engagement

Contact a Global Mergers expert

See all Global Mergers experts

Subscribe to receive our latest Insights.

Subscribe